Gonadorelin: Synthetic GnRH and Its Role Alongside TRT
A synthetic copy of GnRH, the body's own upstream trigger for testosterone — used by TRT clinics to keep the testes active during therapy.
What is Gonadorelin?
Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH), the hypothalamic signal that triggers the pituitary to release LH and FSH, which in turn drive the testes to produce testosterone and sperm. It carries decades-old FDA approval for fertility and diagnostic use, and testosterone-replacement clinics use it — dosed in pulses to mimic the body's natural rhythm — to keep testicular function active alongside exogenous testosterone, similar in purpose to hCG. Head-to-head evidence against hCG, the more established alternative, is mixed, and no study has directly measured its effect on libido itself.
Quick facts
- Half-Life
- ~10-40 minutes
- Class
- Synthetic GnRH (decapeptide, native sequence)
- Brand Names
- Factrel, Lutrepulse (older FDA-approved brands, largely discontinued from mainstream distribution)
- Legal Status
- Prescription-only; FDA-approved for fertility/diagnostic use. TRT-adjacent use to preserve testicular function is off-label but a legitimate prescribed use
- Category
- Hormone Therapy
- Storage
- Store the lyophilized vial refrigerated (2-8°C) or at -20°C, away from light. Once reconstituted, keep refrigerated at 2-8°C and use promptly.
Dosing at a glance
2mg vial + 2mL bacteriostatic water = 1000mcg/mL. Run the numbers in the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.
What the evidence supports
| Claim | Grade | Basis |
|---|---|---|
| Fertility / Testicular Function | Cgrade | Delemarre-van de Waal 1993: pulsatile GnRH restored testicular growth and sperm production in men with hypogonadotropic hypogonadism (n=38). |
Gonadorelin Mechanism of Action
The Body's Own Upstream Testosterone Trigger
Gonadorelin is a synthetic copy of native GnRH, the decapeptide the hypothalamus releases in pulses to trigger LH and FSH secretion from the pituitary — the same upstream signal exogenous testosterone therapy suppresses. By replacing that signal, gonadorelin keeps the testes actively producing their own testosterone and sperm, rather than going dormant.
Why TRT Clinics Use It
Exogenous testosterone shuts down the body's own HPG axis signaling via negative feedback — the testes stop receiving the LH signal and shrink/reduce function over time. Pulsed gonadorelin dosing alongside TRT is meant to keep that signal alive, preserving testicular size and fertility potential, similar in purpose to hCG but acting one step further upstream.
Gonadorelin Dosage and Protocols
Pulsed TRT-Adjacent Dosing
TRT-adjacent protocols commonly dose gonadorelin at ~100mcg subcutaneous, 2-3 times weekly — reflecting its short half-life, which favors more frequent, pulsed dosing over the twice-weekly hCG convention. Doses should be individualized by a prescriber based on response.
Gonadorelin Side Effects and Safety
Generally Mild
Reported effects are generally mild — injection-site irritation and occasional headache. Because it stimulates the same axis as exogenous hormone therapy, hormone-sensitive cancers are treated as a contraindication.
Gonadorelin Research Evidence
Old Approval, Thin Head-to-Head Data
In a 1993 study (Delemarre-van de Waal, n=38) of men with hypogonadotropic hypogonadism, pulsatile GnRH administration restored testicular growth and sperm production. Gonadorelin's use for fertility and diagnostic purposes has decades-old FDA approval. However, head-to-head trial evidence comparing gonadorelin against hCG — the more established TRT-adjunct — for preserving fertility during testosterone therapy is mixed and limited.
Regulatory and Legal Status
Gonadorelin is prescription-only and carries older FDA approval for fertility and diagnostic use. Its use alongside TRT to preserve testicular function is off-label but a legitimate prescribed use through a licensed provider — it is not a controlled substance.
Gonadorelin Stacking and Combinations
Gonadorelin + Testosterone Cypionate
The standard pairing is low-dose, frequent gonadorelin alongside testosterone cypionate or other exogenous androgens, specifically to maintain testicular function and fertility potential during TRT — an alternative to hCG for the same purpose.
Gonadorelin Pharmacokinetics
Very Short Half-Life
Gonadorelin has a plasma half-life of roughly 10-40 minutes, consistent with native GnRH's naturally pulsatile secretion pattern — this short half-life is why it's dosed frequently rather than weekly, unlike longer-acting alternatives like hCG.
Contraindications
- pregnancy
- hormone-sensitive cancers
- known hypersensitivity
Trials and reviews
- Delemarre-van de Waal pulsatile GnRHclinical study1993
Pulsatile GnRH restored testicular growth + sperm production (n=38)
Frequently asked questions
What is a typical Gonadorelin dose?
Published research protocols report 100 mcg, 2–3x weekly. This is the range described in the literature, not a recommendation.
What is the half-life of Gonadorelin?
~10-40 minutes.
Is Gonadorelin backed by strong evidence?
Gonadorelin carries a REGEN research grade of C. REGEN Research Tier C — old FDA approval for fertility/diagnostic use; TRT-adjacent use is well-established in practice but thinly trialed head-to-head.
How is Gonadorelin administered?
Routes reported in the literature: subcutaneous.
Who should avoid Gonadorelin?
Contraindications noted in the literature include pregnancy, hormone-sensitive cancers, known hypersensitivity.
References
- Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone · Delemarre-van de Waal HA · 1993